Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

James Miller

Dentist, Oral and Maxillofacial Surgery Butler, PA Doctor of Dentistry

NPI 1821190547 CMS profile 174136

114 E Diamond St, Butler, PA 16001

Open in the dashboard

General payments

$557

17 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, James Miller of Butler, PA is reported in the CMS Open Payments database as having received $557 across 17 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 45th percentile of Dentist, Oral and Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $32 1
2024 General $14 1
2023 General $72 2
2022 General $112 5
2021 General $113 4
2020 General $93 2
2019 General $122 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • James Miller
  • Dentist, Oral and Maxillofacial Surgery median
  • Middle half of Dentist, Oral and Maxillofacial Surgery
  • National median

In program year 2025, general payments to James Miller were reported at $32. Among 3,834 Dentist, Oral and Maxillofacial Surgery profiles paid that year, the median was $150 and the middle half received between $56 and $423.

Show as a table
Year James Miller Dentist, Oral and Maxillofacial Surgery median Middle half National median
2019 $122 $142 $50–$420 $163
2020 $93 $96 $36–$277 $114
2021 $113 $138 $45–$419 $132
2022 $112 $144 $48–$367 $149
2023 $72 $153 $55–$399 $160
2024 $14 $152 $50–$400 $164
2025 $32 $150 $56–$423 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $359 9 payments
  2. Zimvie Inc. $116 5 payments
  3. Kowa Pharmaceuticals America, Inc. $50 2 payments
  4. Darby Dental Supply, LLC $32 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $375 14 payments
  2. Education $150 2 payments
  3. Debt forgiveness $32 1 payment
Products named General payments · program years 2019–2025
  1. Tapered Screw Dental $139 3 payments
  2. Tapered Screw-Vent Dental $116 5 payments
  3. Tapered Screw Dental $113 4 payments
  4. All T3 Implants $75 1 payment
  5. Seglentis $50 2 payments
  6. Tapered Screw-Vent Dental $32 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 11 drugs

Part D claims

1,541

Median for Oral Surgery (Dentist only): 288

Drug cost

$4,818

Median for Oral Surgery (Dentist only): $1,122

Branded share of claims

29.2%

Median for Oral Surgery (Dentist only): 18.4%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ibuprofen Generic 348 $1,107
Chlorhexidine Gluconate Generic 164 $827
Amoxicillin Generic 331 $758
Penicillin V Potassium Generic 144 $656
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 344 $451
Clindamycin Hcl Generic 80 $287
Clotrimazole Generic 11 $261
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 30 $211
Ibu Ibuprofen Brand 57 $115
Methylprednisolone Generic 13 $81

The 10 drugs with the highest cost, of 11 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 5,440 Part D prescribers listed as Oral Surgery (Dentist only); they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 16 billing codes

Paid by Medicare

$4,095

Medicare's payments for the services billed

Medicare patients

32

Average age 73

Services billed

49

19 women, 13 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 72%
Arthritis 47%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

17 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record